A new clinical trial from Scripps Research in La Jolla aims to make significant gains in the global fight against malaria by ...
Merck & Co. has won U.S. Food and Drug Administration priority review for its application seeking expanded use of its blockbuster cancer drug Keytruda in certain patients with head and neck cancer.
Merck Life Science opens formulation & technology centre in Turbhe, Navi Mumbai: Our Bureau, Bengaluru Tuesday, February 25, ...
Eli Lilly and Company, Johnson & Johnson, Pfizer, Merck & Co., Inc., and Novo Nordisk A/S are the five Pharmaceutical stocks to watch today, according to MarketBeat’s stock screener tool. These ...
The partners will test Summit’s ivonescimab alongside Pfizer’s antibody-drug conjugates in hopes of finding “potentially ...
Detailed results presented at a medical congress help reinforce analyst expectations the drug, called duvakitug, will be competitive with other Crohn’s, colitis medicines in testing.
LOS ANGELES, CA / ACCESS Newswire / February 24, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of ...
Pfizer partners with Summit Therapeutics to advance cancer treatments using ADCs and ivonescimab. Click here to find out why ...
Dogs of the Dow can be described as the 10 highest yielding stocks that are within the DJI. Read more to see the best Dog of ...
In a regulatory filing, the Mumbai-based drug maker said that in 2023 it had settled with three plaintiff groups referred as ...
The majority of the market isn't seeing the bigger picture for these stocks and their underlying companies. Big mistake.
Few big pharma stocks have been bigger winners over the last three years than Eli Lilly and Novo Nordisk. Lilly now ranks as ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results